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Chocolate consumption has been associated with a short-term reduction in blood pressure
and cholesterol, and improvement of insulin sensitivity; however, participants could not be
aware of presenting hypertension or hypercholesterolemia. Moreover, the effect of choco-
late on mental health is uncertain. This study assessed the association of regular chocolate
consumption with the physical (PCS) and mental (MCS) components of health-related qual-
ity of life (HRQL).
Materials and methods
We analyzed data from a cohort of 4599 individuals recruited in 2008–2010 and followed-up
once prospectively to January 2013 (follow-up mean: 3.5 years). Regular chocolate con-
sumption was assessed at baseline with a validated diet history. HRQL was assessed with
the SF-12 v.2 at baseline and at follow-up. Analyses were performed with linear regression
and adjusted for the main confounders, including HRQL at baseline.
Results
At baseline, 72% of the study participants did not consume chocolate, 11% consumed10
g/day and 17% >10 g/day. Chocolate consumption at baseline did not show an association
with PCS and MCS of the SF-12 measured three years later. Compared to those who did
not consume chocolate, the PCS scores were similar in those who consumed10g/day
(beta: -0.07; 95% confidence interval (95% CI): -0.94 to 0.80) and in those who consumed
>10g/day (beta: 0.02; 95% CI:-0.71 to 0.75); corresponding figures for the MCS were 0.29;
95% CI: -0.67 to 1.26, and -0.57; 95%CI: -1.37 to 0.23. Similar results were found for sex, re-
gardless of obesity, hypertension, hypercholesterolemia, diabetes or depression.
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Conclusions
No evidence was found of an association between chocolate intake and the physical or
mental components of HRQL.
Introduction
Chocolate is usually consumed in pleasant situations; many people find it delicious because
chocolate has a characteristic texture, dissolves in the mouth, and has a nice aroma and a slight-
ly bittersweet taste. From a nutritional standpoint, chocolate is energy-rich and has a high con-
tent of fat (saturated and to a lesser extent mono-unsaturated fat) and sugar. It also contains
minerals (potassium, phosphorus, magnesium, and zinc), flavonols, biogenic amines (tyramine
and phenylethylamine), methylxanthines (caffeine and theobromine), and cannabinoid-like
fatty acids.[1]
Chocolate consumption, dark chocolate in particular, has been consistently associated with
better physical health. Specifically, chocolate has been suggested to have short-term benefits on
reducing blood pressure [2–4] and serum cholesterol, [4–7] and on improving insulin sensitivi-
ty; [4,8,9] also, in a number of long-term observational studies, chocolate consumption has
been linked to lower incidence of cardiovascular disease.[2,10,11] However, participants do not
usually perceive changes in biological risk factors for cardiovascular disease. Moreover, the ef-
fect of chocolate on mental health is uncertain because the few studies that have explored this
issue have obtained conflicting results. [12–15]
Health-related quality of life (HRQL) represents the individual perception of well-being in
several spheres of life, including physical and mental aspects. Poorer HRQL has been associated
with greater use of healthcare services [16,17] and increased all-cause mortality. [18,19] To our
knowledge, this is the first study to assess the prospective association of regular chocolate con-
sumption with the physical and mental components of HRQL.
Methods
Study design and participants
Data were taken from a cohort of 6207 individuals aged 18 years and older. Cohort members
were selected through random sampling of participants in the ENRICA study [20] with over-
representation of older adults. Baseline data were collected in 2008–2010 in three stages: first, a
phone interview with a structured questionnaire on health status, lifestyle, morbidity and
health services use; second, a home visit to obtain biological samples (blood and urine); and
third, another home visit to perform a physical exam and to conduct a diet history. Three years
later (fromMay 2012 to January 2013; follow-up mean: 3.5 years), an attempt was made to
contact the subjects again, which was successful in 4887 (78.7%) of cases. The socio-demo-
graphic, lifestyle and clinical characteristics were similar in subjects lost to follow-up and in
those contacted. At follow-up, information was updated by phone interview using the same
questionnaire as at baseline. All persons who collected information at baseline and at follow-up
(nurses to obtain biological samples, and non-health personnel for the rest of the tasks) re-
ceived specific training in the study procedures.
Study participants gave written informed consent. The study protocol was approved by the
Clinical Research Ethics Committee of the La Paz University Hospital in Madrid.
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Chocolate consumption
Chocolate consumption during the year preceding the interview was collected with a validated
computerized diet history developed from that used in the EPIC-Spain cohort study. [21,22]
For chocolate, the energy-adjusted intraclass correlation coefficient between the diet history
and the mean of seven 24-hour recalls was 0.49 in the validation study. Individuals reported
the type of chocolate, the frequency and the amount consumed. Photographs were used to help
estimate the size of the chocolate portion. Specifically, study participants were asked about the
consumption of 25 foods containing chocolate; for this analysis, only milk chocolate bars, dark
chocolate bars, unspecified chocolate, milk chocolate bars with nuts, thick hot chocolate, dark
chocolate bars with nuts, bonbons, candy bars (e.g., Kit-Kat), white chocolate bars, candy bars
(e.g., Mars, Snickers), chocolate for melting and truffles were considered. Finally, we calculated
the total consumption of chocolate in g/day.
Health related quality of life
HRQL was assessed with the Spanish version of the SF-12v.2, which has been validated. [23,24]
The SF-12 is a shorter version of the SF-36 questionnaire, [25] and includes 12 items which
allow for calculating a physical component summary (PCS) and a mental component summary
(MCS), whose values are standardized to a national norm with a mean of 50 and a standard de-
viation of 10. Thus, the SF-12 summaries serve to compare the scores for each study participant
against the mean score in the Spanish population. A higher score in the PCS or the MCS corre-
sponds to better health status. [26]
Potential confounders of the study association
Study participants reported their sex, age, level of education, and consumption of tobacco and
alcohol. Weight, height and waist circumference were measured under standardized condi-
tions. [27] Body mass index (BMI) was calculated as weight in kg divided by the square of
height in m. Abdominal obesity was defined as a waist circumference>102 cm in men and
>88 cm in women. Leisure-time physical activity (MET-h/week) was estimated with the ques-
tionnaire used in the EPIC-Spain cohort study. [28] Sedentary behavior was approximated by
the time (hours/week) spent watching TV. As regards diet, the total energy intake was calculat-
ed by using standard food composition tables, and accordance with the Mediterranean diet was
assessed with the Trichopoulou index (0–2, 3–5, and 6–8 points for low, medium and high ac-
cordance, respectively). [29] Finally, study subjects reported the following physician-diagnosed
diseases at baseline and at the end of follow-up: coronary heart disease, stroke, cancer at any
site, depression requiring treatment, hypertension, diabetes, and hypercholesterolemia.
Statistical analysis
Of the 4887 participants who were contacted at the time of the interview, 4780 were alive. Of
these, we excluded 214 individuals who lacked data on chocolate consumption or HRQL, and
74 with missing data on other variables. Thus, the analyses were conducted with 4599
individuals.
The association of chocolate consumption in 2008–2010 with the PCS and MCS of the
SF-12 in 2013 was summarized with regression coefficients and their 95% confidence intervals
(CI), obtained from linear regression models. Chocolate consumption was categorized into
three groups: no consumption (reference),10 g/day and>10 g/day. Of note is that 10 g is the
standard portion for chocolate intake in Spain. [30] In interpreting the study results, we con-
sidered that only regression coefficients greater than 3 points were clinically relevant. [24,26]
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The linear models were adjusted for HRQL and the rest of the above-mentioned potential con-
founders measured at baseline (2008–2010), and for incident diseases during follow-up (from
2008–2010 to 2012–2013).
Analyses were conducted in the total study sample and each sex separately, because the dis-
tribution of HRQL varies with sex. The analyses were also stratified by general obesity, hyper-
tension, diabetes, hypercholesterolemia, and depression to assess if these variables (which
could be influenced by chocolate intake) mediate or modify the study association. Due to limit-
ed sample size, these analyses used chocolate consumption as a binary variable (yes vs. no).
Statistical significance was set at a 2-sided p<0.05. Statistical analyses were conducted with
Stata v.11.
Results
At baseline, 72% of the study participants did not consume chocolate, 11% consumed10 g/
day and 17%>10 g/day. Among those who consumed chocolate, mean intake was 23.2 g/day
(24.7 in men and 22.2 in women). Milk chocolate and dark chocolate bars were the varieties
with the highest consumption (Table 1)
Compared to those with no chocolate consumption, consumers were more frequently
women, younger, and had higher education; they also showed lower alcohol intake, BMI and
frequency of abdominal obesity, but higher energy intake. As regards to baseline HRQL, the
PCS and the MCS varied little across the categories of chocolate consumption when both crude
and adjusted means were considered (Table 2).
In the adjusted analyses, chocolate consumption at baseline did not show a statistically or
clinically significant association with either the PCS or the MCS scores three years later. Com-
pared to those who did not consume chocolate, the PCS scores were similar in those who con-
sumed10 g/day (beta: -0.07; 95% confidence interval (CI): -0.94 to 0.80) and in those who
consumed>10 g/day (beta: 0.02; 95% CI: -0.71 to 0.75); corresponding figures for the MCS
were 0.29; 95% CI: -0.67 to 1.26, and -0.57; 95% CI: -1.37 to 0.23. Similar results were found in
each sex (Table 3).
Table 1. Chocolate consumption in g/day for the study participants in the ENRICA cohort study (2008–2010) by type of chocolate, among choco-
late consumers.
Total (n = 1272) Men (n = 528) Women (n = 744)
Types of chocolate Mean SD Mean SD Mean SD
Milk chocolate bars 8.0 25.3 8.3 31.1 7.8 20.3
Dark chocolate bars 5.0 12.8 4.6 12.5 5.1 13.0
Unspeciﬁed chocolate 3.2 15.4 4.2 19.8 2.5 11.1
Milk chocolate bars with nuts 3.0 10.7 3.3 10.4 2.7 10.9
Thick hot chocolate 1.7 12.3 1.6 13.6 1.7 11.2
Dark chocolate bars with nuts 0.9 4.7 1.0 5.0 0.7 4.5
Bonbons 0.4 2.6 0.2 1.3 0.5 3.3
Candy bars (e.g., Kit-Kat) 0.4 4.3 0.6 6.1 0.1 2.4
White chocolate bars 0.3 2.7 0.1 1.6 0.4 3.3
Candy bars (e.g.,Mars, Snickers) 0.2 2.4 0.2 3.5 0.1 1.0
Chocolate for melting 0.1 1.9 0.1 2.3 0.1 1.7
Trufﬂes 0.1 0.7 — — 0.1 1.0
Total 23.2 22.1 24.7 38.2 22.2 27.0
SD: Standard Deviation
doi:10.1371/journal.pone.0123161.t001
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Table 2. Baseline characteristics for the study participants in the ENRICA cohort study (2008–2010) according to categories of chocolate
consumption.
Chocolate consumption (g/d)
Overall No consumption  10 g/day > 10 g/day p value
Participants (n) 4599 3327 479 793
Total chocolate consumption, g/day, mean (SD) 6.4 (19.8) 0 5.1 (2.5) 34.1 (36.5) <0.0001
Men, % 49.2 52.1 40.3 42.2 <0.0001
Age, mean (SD) 54.1 (17.2) 55.3 (17.9) 55.1(16.44) 51.1 (17.2) <0.0001
Educational level, %
No formal or primary education 36.7 39.6 32.8 27.1 <0.0001
Secondary education 36.4 34.8 38.0 41.9
University 26.9 25.6 29.2 30.9
Tobacco consumption, %
Never smokers 49.3 23.6 20.0 23.6 0.01
Former smokers 27.4 28.3 23.6 26.0
Current smokers 23.24 48.1 56.4 50.4
Alcohol consumption, g/day, mean (SD) 12.3 (20.1) 13.2 (21.0) 9.6 (16.1) 10.6 (10.5) <0.0001
Body mass index, Kg/m2, mean (SD) 27.4 (4.6) 27.6 (4.5) 27.0 (4.4) 26.9 (4.8) <0.0001
Abdominal obesity, % 42.8 43.9 38.8 40.7 <0.0001
Leisure time physical activity, METs h/week, mean
(SD)
26.4 (20.4) 26.3 (20.3) 27.1 (21.4) 26.2 (20.0) 0.67
Time spent watching TV, (h/week), mean (SD) 15.0 (10.2) 15.2 (10.2) 15.0 (10.5) 14.8 (9.9) 0.55
Adherence to the Mediterranean diet,* %
Low adherence (0–2 points) 15.7 16.3 11.7 22.6 <0,0001
Medium adherence (3–5 points) 58.5 61.5 66.0 60.0
High adherence (6–8 points) 25.7 22.2 22.3 18.0
Total energy intake, kcal/day, mean (SD) 2167 (624) 2101 (617) 2166 (525) 2446 (635) <0.0001
Prevalent diseases at baseline, %
Coronary heart disease 0.8 0.9 0.6 0.4 0.20
Stroke 0.6 0.6 0.6 0.5 0.94
Cancer 1.2 1.4 0.6 0.8 0.10
Depression 6.9 6.9 6.5 7.3 0.85
Incident diseases during follow-up, %
Coronary heart disease 0.7 0.6 0.6 0.8 0.92
Stroke 0.8 0.9 0.2 0.8 0.30
Cancer 1.9 2.1 2.5 1.0 0.09
Depression 6.8 6.8 6.5 7.1 0.92
Cardiovascular risk factors, %
Hypertension ** 44.0 45.8 39.6 39.1 0.0004
Diabetes† 9.3 10.4 8.5 5.6 0.0002
Hypercholesterolemia‡ 59.1 59.6 58.3 56.7 0.30
Physical component summary, mean (SD) 48.9 (10.8) 48.7 (10.9) 49.2 (9.6) 49.7 (10.2) 0.37
Mental component summary, mean (SD) 51.1 (10.2) 51.1 (10.4) 51.8 (9.1) 50.6 (9.8) 0.57
Physical component summary, mean (SD)║ 48.9 (9.4) 48.9 (9.5) 48.7 (9.5) 48.9 (9.7) 0.93
Mental component summary, mean (SD)║ 51.0 (9.5) 50.9 (9.6) 51.8 (9.5) 50.9 (9.7) 0.56
SD: Standard Deviation; MET: Metabolic Equivalents; TV: television;
* Trichopoulou score.
** Hypertension was deﬁned as systolic pressure 140 mm Hg, diastolic pressure 90mmHg, or use of antihypertensive drugs.
†Diabetes mellitus was deﬁned as serum glucose 126 mg/dl or use of antidiabetic drugs.
‡Hypercholesterolemia was deﬁned as total serum cholesterol 200 mg/dl or use of hypolipidemic drugs.
║Adjusted for sex, age (18–44,45–64,65 and over), educational level (no formal or primary education; secondary education; university), tobacco
consumption (never smokers, former smokers, current smokers), alcohol consumption g/day (quartiles), body mass index kg/m2 (quartiles), abdominal
obesity (yes/no), leisure time physical activity METs-h/week (quartiles), time spent watching television h/week (quartiles), adherence to the Mediterranean
diet (low adherence 0–2 points, medium adherence 3–5 points, high adherence 6–8 points), total energy kcal/day (quartiles) and prevalent diseases
(coronary heart disease, stroke, cancer and depression).
doi:10.1371/journal.pone.0123161.t002
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When chocolate consumption was classified as a dichotomous variable, the adjusted-mean
of the PCS three years later was 48.1 among participants without chocolate consumption and
48.2 among those who consumed any amount of chocolate (p-value = 0.78). The correspond-
ing figures for the MCS were: 51.5 and 51.4 (p-value = 0.76)."
Lastly, no association was observed between chocolate consumption and HRQL when the
analyses were stratified by general obesity, hypertension, hypercholesterolemia, diabetes melli-
tus, and depression (Table 4).
Discussion
In this 3-year prospective study in the adult population of Spain, chocolate consumption did
not show an association with either the physical or the mental components of HRQL.
As regards the potential effect of chocolate on physical health, chocolate consumption low-
ers blood pressure and cholesterol, and improves insulin sensitivity and vascular function. [2–
9] However, it seems that the effects of chocolate on blood pressure are apparent mostly in in-
dividuals with hypertension or prehypertension, [31,32] and the improvement in lipid profile
resulting from chocolate intake has been observed specifically in those with cardiovascular dis-
ease risks. [6] Of note, we found no association between chocolate and better physical HRQL,
even in subjects diagnosed with hypertension, hypercholesterolemia or diabetes. Moreover, in
a recent small trial with 37 g/day of dark chocolate administered during 6 weeks, no effect of
chocolate was observed on blood pressure, serum lipids or C-reactive protein; chocolate con-
sumers only showed higher pulse rates at 3 and at 6 weeks. [15] Lastly, the type of cocoa
Table 3. Linear regression coefficients (95% confidence interval) of the physical andmental components of the SF-12 in 2012–13 by chocolate
consumption categories.
Chocolate consumption (g/day) n Physical component summary Mental component summary
Total participants
No consumption 3327 1.00 (Ref.) 1.00 (Ref.)
 10 g/day 479 -0.07 (-0.94 to 0.80) 0.29 (-0.67 to 1.26)
> 10 g/day 793 0.02 (-0.71 to 0.75) -0.57 (-1.37 to 0.23)
p for trend 0.87 0.32
Men
No consumption 1734 1.00 (Ref.) 1.00 (Ref.)
 10 g/day 193 -0.06 (-1.35 to 1.22) -0.17 (-1.53 to 1.19)
> 10 g/day 335 0.001 (-1.04 to 1.04) 0.27 (-0.82 to 1.37)
p for trend 0.98 0.70
Women
No consumption 1593 1.00 (Ref.) 1.00 (Ref.)
 10 g/day 286 0.006 (-1.20 to 1.21) 0.95 (-0.43 to 2.32)
> 10 g/day 458 0.09 (-0.93 to 1.11) -0.83 (-2.01 to 0.34)
p for trend 0.87 0.32
*p <0,05;
** p <0,01.
Model adjusted for sex, age (18–44,45–64,65 and over), educational level (no formal or primary education; secondary education; university), tobacco
consumption (never smokers, former smokers, current smokers), alcohol consumption g/day (quartiles), body mass index kg/m2 (quartiles), abdominal
obesity (yes/no), leisure time physical activity METs-h/week (quartiles), time spent watching television h/week (quartiles), adherence to the Mediterranean
diet (low adherence 0–2 points, medium adherence 3–5 points, high adherence 6–8 points), total energy kcal/day (quartiles), prevalent diseases (coronary
heart disease, stroke, cancer and depression), incident diseases (coronary heart disease, stroke, cancer and depression), physical or mental component
summaries at baseline, as appropriate.
doi:10.1371/journal.pone.0123161.t003
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Table 4. Linear regression coefficients (95% confidence interval) of the physical andmental components of the SF-12 in 2012–13 by chocolate
consumption categories, stratified by educational level, lifestyles and prevalent diseases.
Stratiﬁed models Chocolate consumption n Physical component summary Mental component summary
Educational level
No formal or primary education No 1318 1.00 (Ref.) 1.00 (Ref.)
Yes 372 -0.58 (-1.79 to 0.63) 0.19 (-1.11 to 1.50)
Secondary education or univesity No 2009 1.00 (Ref.) 1.00 (Ref.)
Yes 900 0.23 (-0.44 to 0.90) -0.44 (-1.20 to 0.32)
Leisure time physical activity
Below the median No 1681 1.00 (Ref.) 1.00 (Ref.)
Yes 648 0.23 (-0.69 to 1.15) -0.69 (-1.67 to 0.29)
Above the median No 1646 1.00 (Ref.) 1.00 (Ref.)
Yes 624 -0.30 (-1.09 to 0.49) 0.32 (-0.59 to 1.23)
General obesity
With general obesity (BMI 30 kg/m2) No 880 1.00 (Ref.) 1.00 (Ref.)
Yes 266 -0.72 (-2.15 to 0.71) -0.74 (-2.28 to 0.79)
Without general obesity (BMI <30 kg/m2) No 2447 1.00 (Ref.) 1.00 (Ref.)
Yes 1006 0.22 (-0.44 to 0.87) -0.03 (-0.76 to 0.71)
Hypertension
With hypertension No 1514 1.00 (Ref.) 1.00 (Ref.)
Yes 496 -0.10 (-1.13 to 0.93) 0.14 (-0.93 to 1.21)
Without hypertension No 1813 1.00 (Ref.) 1.00 (Ref.)
Yes 776 0.09 (-0.64 to 0.82) -0.42 (-1.28 to 0.44)
Diabetes
With diabetes No 341 1.00 (Ref.) 1.00 (Ref.)
Yes 84 1.24 (-1.43 to 3.91) 1.97 (-0.72 to 4.67)
Without diabetes No 2986 1.00 (Ref.) 1.00 (Ref.)
Yes 1188 -0.12 (-0.73 to 0.50) -0.36 (-1.04 to 0.33)
Hypercholesterolemia
With hypercholesterolemia No 1980 1.00 (Ref.) 1.00 (Ref.)
Yes 545 0.11 (-0.72 to 0.95) -0.44 (-1.35 to 0.46)
Without hypercholesterolemia No 1347 1.00 (Ref.) 1.00 (Ref.)
Yes 727 0.06 (-0.80 to 0.92) -0.27 (-1.26 to 0.72)
Depression
With depression No 231 1.00 (Ref.) 1.00 (Ref.)
Yes 89 -0.79 (-3.87 to 2.28) -3.07 (-6.68 to 0.54)
Without depression No 3096 1.00 (Ref.) 1.00 (Ref.)
Yes 1183 0.07 (-0.54 to 0.68) -0.05 (-0.72 to 0.62)
*p <0,05;
** p <0,01.
Model adjusted for sex, age (18–44,45–64,65 and over), educational level (no formal or primary education; secondary education; university), tobacco
consumption (never smokers, former smokers, current smokers), alcohol consumption g/day (quartiles), body mass index kg/m2 (quartiles), abdominal
obesity (yes/no), leisure time physical activity METs-h/week (quartiles), time spent watching television h/week (quartiles), adherence to the Mediterranean
diet (low adherence 0–2 points, medium adherence 3–5 points, high adherence 6–8 points), total energy kcal/day (quartiles), prevalent diseases (coronary
heart disease, stroke, cancer and depression), incident diseases (coronary heart disease, stroke, cancer and depression), physical or mental component
summaries at baseline, as appropriate.
doi:10.1371/journal.pone.0123161.t004
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processing modifies the nutritional content of chocolate, particularly of the dark and white va-
rieties, reducing the level of flavonoids and the antioxidant capacity. [33,34] In any case, these
effects are not usually perceived, and the diagnosis of hypertension or hypercholesterolemia in
frequent results from periodic screening or is a casual finding. Thus, the effect of chocolate on
these biological factors may not translate into a better health perception. [35,36]
Although the negative effect of obesity on HRQL is well documented, [37] the association
between chocolate intake and obesity is still uncertain. In fact, while chocolate is energy-rich
and is frequently consumed as a snack, two cross-sectional studies have found an inverse asso-
ciation between chocolate intake and BMI. [38,39]
As regards chocolate and mental health, three cross-sectional studies have reported incon-
sistent associations. The first study was an exploratory investigation with 362 Swedish women,
in which higher intake of sweet foods (specifically chocolate) correlated with more severe psy-
chiatric symptomatology. [12] In the second study, which was conducted with over 1300 elder-
ly men in Finland, those with a preference for chocolate over other types of candy reported
better scores for subjective health, feelings of happiness and loneliness, and the Zung depres-
sion scale. [13] In contrast, a third study with 1018 adults from the U.S. showed that a higher
consumption of chocolate was associated with a better score on the Center for Epidemiologic
Studies Depression scale. [14]
Our results are in line with those from a trial with 101 subjects, which did not observe any
effect of 37 g/day of chocolate during 6 weeks on any neuropsychological variables, including
memory, thinking processes, mood and energy.[15] Several researchers have emphasized that
the possible benefits of chocolate on mood, if any, are short-lived. [40–43] Match et al. reported
that the mood effects of chocolate last for only 3 minutes, and derive mostly from its palatabili-
ty. [43] Another study found that the reduced tiredness associated with chocolate intake lasts
for only 1 hour. [44] In fact, phenylethylamine (a component of chocolate involved in the path-
ogenesis of depression) is metabolized quickly, with a half-life of only 5–10 minutes. [45]
Therefore, Benton et al. concluded that the levels of psychoactive substances provided by choc-
olate were several orders of magnitude less than those needed to produce a pharmacological ac-
tion. [46]
It has been suggested that depressed individuals may consume chocolate as a sort of "self-
medication," which temporarily relieves symptoms by increasing serotonin centrally, due to the
effect of tryptophan contained in chocolate. [47] Our results, however, showed no association be-
tween chocolate consumption and better health among those with diagnosed depression.
This study had some strengths and limitations. Among the strengths are the longitudinal
design and the large sample of community-dwelling adults. Moreover, chocolate intake and
HRQL were assessed with validated instruments. Lastly, the analyses accounted for a good
number of potential confounders.
The main limitation was that diet was self-reported; therefore certain underreporting cannot
be ruled out, particularly among the obese. Thus, obese participants could underestimate choc-
olate consumption because of a social desirability bias. Given that obesity is associated with
poorer HRQL, this could lead the study association to the null. However, the main results were
also found among the individuals with normal BMI. Another limitation is that chocolate could
have been consumed for a longtime before the diet measurement at baseline. Our analyses also
assume that chocolate consumption stays similar throughout the follow-up period. However,
these limitations would be of greater importance had the observed association been positive,
because it could be due to chocolate consumption before or after the study baseline. In any
case, our results should be confirmed by an appropriately conducted clinical trial Finally, choc-
olate consumption in the study sample (and in Spain as a whole) was relatively low; the average
consumption among chocolate consumers was 23.2 g/day, which is substantially lower than in
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central European countries and the U.S. [48] Thus, our results may not apply to higher choco-
late consumers such as those in these countries.
In conclusion, in this large prospective study, we have found no evidence of beneficial effects
of regular consumption of chocolate on HRQL. However, our results do not exclude a transient
association between chocolate and certain dimensions of subjective health and wellbeing,
which merit further investigation.
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